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An ino~itol.phosphate.contatninll $1~t¢osphin~o]tpid, not reported ~arli,cr, wax isolated rrom human eattdu equina. Structural charael©rization 
~howed the Ijl)'¢osphln~tolipid to b~ ino~itol.pho=~photyl.2(3) ttalactos~leeramide, Th  conc~ntr=ttion varied I~tween 25 and 2~0 nmOl/ll frcd~ ti~t~tte, 
Inositol.pltosphat©; Galaetos)'lccramide; Glyeo~phlnpolipid: Human l~ripheral nerv~ 
1. INTRODUCTION 
Acidic glycosphingolipids in mammals can be divided 
into 3 groups with regard to their acidic components. 
These groups are sialic acid-containing (gangliositdes), 
sulfate-containing (sulfatides), and sulfatc-giucuronic 
acid-containing lycosphingotipids [1]. A fourth group 
of  glycosphingolipids has been found in various species 
of  plants, yeasts, bacteria and fungi which contain an 
inositol-phosphate moiety with the basic core cerarnid¢- 
phosphate-inositol [1,2]. The present paper describes 
the isolation and characterization of an inositof 
phosphate-containing lycosphingolipid from human 
cauda equina with the phosphate group bound to galac- 
tosylceramide instead of ceramide. This type of acidic 
glycosphingolipid has neither been rcported in mam- 
mals nor in any other species. 
2. MATERIALS AND METHODS 
2,1. MateriaLs 
Sarnples of cauda equina were obtained for examination frorrt tile 
Department of Forensic Medicine, from subjects a~,ed 25-90 years, 
who had died in accidents, Silica gel 60, 230-400 mesh, and glass 
backed HPTLC plates of silica gel 60 were from Merck, Darmstadt 
(Germany), Sephadex G-25 and DEAE-Sepharose fast flow were 
from Pharmacia (Uppsala Sweden). SpherosiI-DEAE-Dextran Was a 
girt from Institute Merieux (Lyon, France), All organic solvents used 
were of HPLC quality, All other chemicals used were of analytical 
quality and used without further purification, Gangliosides and 
neutral glycolipids used as references were all isolated from human 
sources and clmrm..,;rized by FAB-MS in out' laboratcJry, 
2,2. Isolation of the ittositol-containing compound 
Samples of cauda equina were extracted as described by Sven- 
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ncrholm eta l .  (1991). Bioehim, Biophys. Aetm manuscript in 
preparation, A mono~ialotlanttliostd¢ fraetioa was obtained from 
Spherosil.DEAE.dextran ion-excharqle eltromatography by our 
roudrm method [31. Tile monosialogang|ioside fraction was; desalted 
by dialysis and after ev~oratinl l  dissolved in: chloroform/metha. 
nol/wnter 6.~:25:4 tv/v). The c,~tract was applied to a silica set column 
(600 x 10 ram) and eluted with tile same solvent. Fractions containing 
orcinol positive material wilh HPTLC migration slightly faster than 
gatt~lliu~ide GM2 (A'¢~stam 1,05) in the solvent system chloroform/ 
metitanol/0,25g'o aqueous KCI 50:40:10 (v/v) were collected. Con- 
taminatin8 ganBliosides were removed from tile combined fractions 
by treatment with I M formic acid for 30 rain at 100"C [4], After 
neutralization and dialysi.% aslaloglycolipids formed were removed by 
ion.exchange chronlatography On Spherosil-OEAE-dextran, Tile 
:~cidic orcinol-positive compound was ehJted as before with 0.02 M 
potassium acetate in methanol and detailed by dialysis, 
2.3, A.al>,tical methods 
The quantitative composition of the carbohydrate moiety was 
determined as alditol acetates by GLC with mannose as internal stan- 
dard [5], Sphingosine was assayed by a modification or the metl~yl 
orange method of Lamer and Trams [6], l.ipid pttospllorous was 
determined as described by Svennerholm and Vanter [7], Mild acid 
hydrolysis was performed with 0,05 M HCI ia methanol for 16 h ,at 
20°C, 0,3 M HCI in chloroform/methanol 2:1 Iv/v) for 25 rain at 
60°C, or 0.05 M aqueous HzSO.= for 60 rain at 80°C, After hydrolysis 
the samples were neutralized by a small amount of Ag,CO~ and 
purified on 0,3 g of Sephadex G-25 [8], The glycosphingolipid pro. 
ducts were analyzed by HPTLC with chloroform/methanol/O,25% 
aqueous KCI 50:40:10 (v/v) as developing solvent and visualized with 
the orcinol reagent [9], Alkaline treatment was performed with 0,5 M 
KOH n 50°70 aqueous methanol for 20 h, After neutralization with 
acetic acid the samples were desaited and analyzed as above, 
Permethylation and analysis of partially metl~ylated aldito] acetates 
were carried out as described previously [I0], Fast atom 
bombardment-mass spectrometry (FAB-MS) or the permethylated in.
tact substance was performed on a VG 7070E mass spectrometer [I 1], 
Analysis of tile cera mide composition was carried out as described by 
Mfinsson et al [121, 
3. RESULTS AND D!SCUSS!ON 
The isolated glycosphingolipid contained sphingo- 
sine, galactose, phosphate and myo-inositol in the ratio 
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Fil~. I; Positive ion I;'AB.MS ~pe~lrum or p~rmethl¢lalcd ino,;ilol. 
cont.'tinln~t itl~,'~:o',,phini~olipJd from huntan periplteral nerve, 
1.0:0.9:1.0:i, I Acidic treatment of the substance with 
0,05 M HCI in methanol at 20*C yielded 50°70 of a prod- 
uct with the same HPTLC migration as reference galac- 
tosylCel'amide while the product yields with 0,3 M HCI 
in t:hloroform/methanol 2:1 at 60"C or 0,05 IM aqueous 
H.,SO.~ at 80"C were 100%. Alkaline treatment yielded 
90% of the same product. FAB-MS of the 
permethylated product showed molecular iotas cor- 
responding to monohexosyl ceramide. The most promi- 
nent ones were found at m/z 896,894,864 (896-32) and 
862 (894-32) representing monohex0syl ceramide with 
fatty acids C 24:0 and C 24:1 and 4-sphingenine as 
spl~ingosine base, Ions at m/z 219 and 187 (219-32) 
showed a terminal hexose, Analysis of tire partially 
methylated alditol acetates gave 2,3,406-Me.t-Gal s the 
only sugar, which shows that the obtained product after 
acid methanolysis was galactosylceramide, 
When the intact permethylated glycosphingolipid was 
analyzed by FAB-MS (Fig, 1) the most abundant 
molecular ion (M +H) was found at m/z 1208 cor- 
responding to the composition inositol-phosphate- 
galactose.ceramide with 24:0 fatty acid and 
4-sphingenine, Loss of methanol resulted in the ion at 
m/z 1176, Ions at m/z 1206 and 1176 represented the 
same composition with 24:1 fatty acid. Addition of 
thioglycerol to the molecular species containing 24:1 
fatty acid resulted in ions at m/z 1314 and 1282. The ion 
found at m/z 858 represented the molecular iota species 
after loss of the acyl chain (M + 2H-acyl) confirming 
4-sphingenine as the most abundant long chain base. 
The ion found at m/z  531 is the oxonium ion (inositol. 
phosphate-galactose) obtained after elimination of the 
ceramide portion from the molecular ions, The most in- 
tense ions in the ceramide region were found at m/z 660 
and 658 corresponding to the fatty acids 24:0 and 24:1 
with 4-sphingenine asthe long chain base. 
Permethylation analysis of the intact glyco- 
spingolipid showed a mixture of 3,4,6-Me3-Gal and 
2.4,6-Me3-Gal in the ratio 0.7:0.3 showing substitution 
of the galactose moiety both at C-2 and C-3 position, 
Thi~ mixture may be caused by pl~o~pllate ester mlitra. 
lion durinil the perm¢th~,latlon procedt, re [I,~]~ Analyli~t 
of the Ions ¢:h~in ba~e composition ~howed two major 
components. 4-sphin~enine (6]%) =nd sphtn~mnine 
(20ot0), The unsubstituted fatty t~cid~ 24:0 (33%) and 
24:1 (26%} were the dominating ones while h 24:0 ~:on- 
stituted 47~rAt Of the 2-hydroxy fatty acids, The propor. 
lion between unsubstituted and, 2.hy~:lroxy fatty acids 
was 4:1. 
The combined structural analyses or the unknown 
glycosphinl~olipid isolated from httman eauda equina 
Stli/$¢sts the following, structure for the major compo- 
neat, inositol.phosphate.2GaI.Cer and ino~itol. 
phosphate.3GaI.Cer fo the minor eompollent, 
Tl~e concentration of these inositol-phosphate. 
containing lycosphingolipids varied between 25 and 30 
nmollg fresh tissue, A possible function of this new 
glycosphingolipid, inositol-phosphoryl-galactosyi-cera- 
rnide, is to anchor proteins to the plasma membrane in
a similar way as described for the glycosyl-phosphatidyl 
inositol anchors (for review, see [141). In these struc- 
tures the C-terminal carboxyl group ef  a protein is at- 
tached to a carbohydrate chain linked to a phosphatidyl 
inositol molecule located in the lipid layer The lipid 
portion of the new lipid contains, except sphingosine, 
very long-chain unsubstituted-and 2-hydroxy fatty 
acids, This composition will give a less fluid lipid por- 
tion than that of phosphatidyl inositol, which contains 
predominantly stearic acid and arachidonic acid. With 
the larger rigidity of the lipid portion of inositol- 
phosphoryl-galactosylceranaide a new glyco- 
sphingolipid might be a more stable anchor in the mem- 
brane than phosphatidyl inositol, 
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